SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-010224
Filing Date
2017-05-10
Accepted
2017-05-10 16:02:26
Documents
58
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q enta-10q_20170331.htm 10-Q 2069030
2 EX-31.1 enta-ex311_7.htm EX-31.1 16195
3 EX-31.2 enta-ex312_8.htm EX-31.2 16181
4 EX-32.1 enta-ex321_6.htm EX-32.1 8924
5 GRAPHIC g20170510155132657615.jpg GRAPHIC 40542
  Complete submission text file 0001564590-17-010224.txt   6864692

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT enta-20170331.xml EX-101.INS 1629106
7 XBRL TAXONOMY EXTENSION SCHEMA enta-20170331.xsd EX-101.SCH 33776
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enta-20170331_cal.xml EX-101.CAL 47952
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enta-20170331_def.xml EX-101.DEF 103892
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20170331_lab.xml EX-101.LAB 288458
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20170331_pre.xml EX-101.PRE 241305
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 17830160
SIC: 2834 Pharmaceutical Preparations